Atezolizumab trials for Small Cell Lung Cancer ( SCLC )

All Atezolizumab trials · All Small Cell Lung Cancer ( SCLC ) trials

Phase breakdown

Recruiting trials studying Atezolizumab for Small Cell Lung Cancer ( SCLC )

• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
  NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
  NCT07339059 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
  NCT07226999 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 83 locations

Common questions

How many trials study Atezolizumab for Small Cell Lung Cancer ( SCLC )?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.